title: [Correction of immune thrombocytopenia associated with hepatitis C virus infection after combination therapy with interferon alpha and ribavirin].
authors.forename: J P
authors.initials: JP
authors.lastname: Lagasse
authors.forename: X
authors.initials: X
authors.lastname: Causse
authors.forename: J M
authors.initials: JM
authors.lastname: Boulet
authors.forename: H
authors.initials: H
authors.lastname: Djarech
authors.forename: M P
authors.initials: MP
authors.lastname: Ripault
authors.forename: D
authors.initials: D
authors.lastname: Labarriere
mesh_terms: D005260:Female; D006526:Hepatitis C / Q000188:drug therapy*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D008875:Middle Aged; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000821:virology*; D011994:Recombinant Proteins; D012074:Remission Induction; D012254:Ribavirin / Q000627:therapeutic use*
chemical_list: D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D012254:Ribavirin